PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 30 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
Chloroform fractions reduced HaCaT cell viability, induced apoptosis, and downregulated inflammatory markers in vitro and in vivo (IMQ-induced mouse model) [PMID:40143083].
Fraction DW-F5 prevented metastasis and angiogenesis in NOD-SCID mice [PMID:26061820].
Topical application of latex proteases augmented healing of excision wounds in mice [PMID:23838477]. Methanolic extract of fresh leaves showed wound healing potential in excision models [PMID:41563499].
Ethanolic and bark extracts demonstrated cytotoxic and apoptotic activity against KB oral cancer cell lines in vitro [PMID:39157850, PMID:40439388].
Bark extracts showed antinociceptive activity in acetic acid-induced writhing tests in mice, comparable to acetylsalicylic acid [PMID:12165341].
Evidence summary
PubMed sources
- 1.PMID: 24600194 (2014) — A review on phytochemical, pharmacological, and pharmacognostical profile of Wrightia tinctoria: Adulterant of kurchi. · Pharmacognosy reviews
- 2.PMID: 32905089 (2020) — Influence of phytochemicals in induced psoriasis (Review). · Experimental and therapeutic medicine
- 3.PMID: 41563499 (2026) — Wound healing potential of methanolic extract of Wrightia tinctoria fresh leaf. · Die Naturwissenschaften
- 4.PMID: 26061820 (2015) — DW-F5: A novel formulation against malignant melanoma from Wrightia tinctoria. · Scientific reports
- 5.PMID: 39157850 (2024) — Evaluation of in vitro anti-cancer potential and apoptotic profile of ethanolic plant extract of Wrightia tinctoria against oral cancer cell line.